Nurse Practitioner, Acute Care · Rochester, NY
NPI
1225669831
Since 2020
Specialty
Nurse Practitioner, Acute Care
Code 363LA2100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1425 Portland Ave
Rochester, NY, 14621
Phone (585) 922-4000
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,912
129 services
Medicare patients, 2024
65
Average age 75
Drug cost, 2024
$422K
1,048 prescriptions
Company payments, 2025
$88.85
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rachel M Boyan was code 99233 (hospital e&m - subsequent), 20 times for 14 patients. In total Rachel M Boyan billed 129 services in 10 codes, and Medicare paid $5,912.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 20 | 14 | $81.20 | $1,624 |
| 99214 Office E&M - Established | Facility | 16 | 16 | $54.65 | $874 |
| 99213 Office E&M - Established | Facility | 15 | 15 | $35.94 | $539 |
By year: 2022 $8,552 for 164 services; 2023 $3,820 for 76 services; 2024 $5,912 for 129 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rachel M Boyan prescribed most often to Medicare patients was Donepezil Hcl, with 85 prescriptions and refills. In total Rachel M Boyan wrote 1,048 Medicare prescriptions that cost $422K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 85 | 197 | 61 | $739 |
| Levetiracetam Generic | 47 | 106 | 20 | $1,416 |
| Sertraline Hcl Generic | 45 | 86 | 24 | $237 |
| Ubrelvy Ubrogepant | 43 | 43 | 15 | $44K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 43 | 90 | 22 | $2,225 |
| Fluoxetine Hcl Generic | 42 | 112 | 31 | $419 |
| Topiramate Generic | 41 | 67 | 12 | $329 |
| Emgality Pen Galcanezumab-Gnlm | 40 | 63 | Under 11 | $46K |
| Mirtazapine Generic | 40 | 80 | 26 | $697 |
| Emgality Syringe Galcanezumab-Gnlm | 36 | 36 | Under 11 | $62K |
| Memantine Hcl Generic | 29 | 50 | 14 | $626 |
| Nurtec Odt Rimegepant Sulfate | 29 | 35 | Under 11 | $57K |
| Rizatriptan Rizatriptan Benzoate | 26 | 28 | Under 11 | $696 |
| Sumatriptan Succinate Generic | 23 | 27 | Under 11 | $253 |
| Trazodone Hcl Generic | 23 | 41 | 13 | $127 |
Brand drugs: 239 claims; generic drugs: 809 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rachel M Boyan $88.85 ($88.85 in general payments such as food, travel and fees) from 3 companies. The largest payer was MDD US Operations, LLC with $41.57.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.